South America Medical Oxygen Concentrators Market share|report|forecast to 2026
The South America medical oxygen concentrators market is valued at US$ XX Mn in 2018 and is expected to grow at a CAGR of 7.2% over the forecast period to reach a US$ 479.38 Mn by 2026.
(EMAILWIRE.COM, November 05, 2019 ) Market Overview
An oxygen concentrator is a device that concentrates the oxygen from a gas supply by selectively removing nitrogen to supply an oxygen-enriched product gas stream. Medical oxygen concentrators are mainly in hospitals or at home to produce oxygen for patients.
Market Dynamics
The rising prevalence of asthma and COPD is one of the key factors driving the South America medical oxygen concentrators market, as these patients require purified oxygen. COPD is the most common disease in elderly population. It is a progressive illness that takes several years to develop. Most people are at least 40 years old when symptoms of COPD first appear. Its not impossible to develop COPD as a young adult, but it is rare. According to the Brazil Statistical Institute in 2017, in Brazil, people aged 65 and above are expected to reach 36% by 2050 and major percentage of asthma and COPD patients are of geriatric population. According to the National Health Survey in 2018, in Brazil, asthma affected more than 6 million adults.
In addition, increasing number of ICU cases is fueling the South America oxygen concentrators market. In critical care, the monitoring is essential to the daily care of ICU patients, the decisive endpoint is the supply of oxygen to tissues according to their metabolic needs in order to fuel mitochondrial respiration, therefore enhanced and purified oxygen supply is required in intensive care unit. According to Brazilian Critical Care Society in 2016, there were approximately 36,000 ICU beds in Brazil which is one of the largest number of ICU beds in the world per population. These ICU require oxygen concentrators to deliver purified oxygen. There were 25 ICU beds per 100,000 inhabitants 7.6 public ICU beds per 100,000 inhabitants.
However, the high cost of devices is hampering the growth of the South America medical oxygen concentrators market. The main cause of this extremely high cost is that current testing methods of evaluating medical oxygen concentrators are extremely time consuming and expensive as many patients must be tested over a long period of time. In case of bigger stationary oxygen concentrators, the initial set up of these concentrators is high which restrains the end-users from upgrading to the latest models. For instance, Oxygo portable ultra light medical oxygen cylinder is priced at $ 129 whereas the basic oxygen concentrator prices at $435. The maintenance and insurance of these devices are hampering the demand of oxygen concentrators market
Market Segmentation
By product type, the medical oxygen concentrators market is segmented into portable oxygen concentrators and stationary oxygen concentrators. Portable medical oxygen concentrators market holds 66% of market share in 2018, and is expected to increase by 67% by 2026, for South America medical oxygen concentrators market. A portable oxygen concentrator (POC) is a device used to provide oxygen therapy to people that requires greater oxygen concentrations than the levels of ambient air. Portable concentrators are made small enough to carry in one arm, in a backpack or attach to a cart or walker so the patient can move about freely at home or while traveling. Portable concentrators weighs between 5 and 20 pounds and many come with carrying cases or carts for additional convenience when compared to stationary oxygen concentrators. Portable oxygen concentrators provide greater flexibility for respiratory patients who do not require high doses of oxygen and they can run on a variety of power sources and can charge from a wall outlet, a car adapter, or a battery pack. Manufacturers are trying to enhance the portable concentrators to match the reliability and flow rates of stationary concentrators with the portability and convenience of a portable concentrator
By end-user, the hospital medical oxygen concentrators market holds largest market share of about 36% of market share in 2018, and is expected to increase by 37% by 2026, for South America medical oxygen concentrators market. Most of the oxygen concentrators are expensive, and hospitals can afford these devices as they have sufficient budget for all their medical equipment when compared to other medical facilities. The increasing number of hospitalizations for acute and chronic conditions such as respiratory disorders and cardiac diseases are boosting the requirement of oxygen concentrators in hospitals. According to International Journal Cardiovascular Science in 2017, coronary artery disease (CAD) accounted for approximately 250,000 hospitalizations. The high number of patients being admitted for respiratory conditions is compelling hospitals to spend more on these systems, leading to a rise in the revenue of oxygen concentrators
Download free sample: https://www.datamintelligence.com/download-sample/south-america-medical-oxygen-concentrators-market
Geographical Analysis
Brazil and Argentina are the two largest markets for Medical Oxygen Concentrators in the region, Rest of the countries in the regions cumulatively accounted for less than 40% of the South American market value for Medical Oxygen Concentrators in 2018. Relatively advanced healthcare infrastructure, healthcare spending and high population density in Brazil compared to other South American countries is the primary factor for the dominant share of the respiratory equipment market in the region. The market for respiratory equipment is untapped in many South American countries due to low healthcare access and low disease awareness. For instance, Argentina represents a potential market for respiratory equipment which more than 300,000 health professional and 5000+ hospitals in the country.
Competitive Landscape
The South America medical oxygen concentrators market is dominated by major players including Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Inogen Inc., Invacare Corporation, Dragerwerk AG & Co. KGaA, TEIJIN LIMITED, DeVilbiss Healthcare LLC, GCE Healthcare, O2 Concepts, LLC, among others.
he key players are focusing on broadening their product portfolio by partnering with or acquiring smaller companies or by launching new products. For instance,
In March 2019, Invacare launched the new BirdieEVO mobile hoist family.
In January 2019, ResMed, a leader in respiratory care medical devices and out-of-hospital care software launched premier portable oxygen concentrator, Mobi , which offers an optimal balance of oxygen delivery, weight and battery life so that millions of people with chronic obstructive pulmonary disease (COPD) or other chronic diseases can enjoy Res Med-quality oxygen therapy wherever they go.
In 2019, Inogen, leading medical device company recently launched Inogen One G5 portable oxygen concentrator. The Inogen One G5 is much superior to other portable oxygen concentrators because it has the highest oxygen production capacity per pound of weight, amounting to 1260 ml
In 2018, Caire Inc launched portable oxygen concentrator, the FreeStyle Comfort. The device weighs only 5 lbs and desigend with a comfort curve to rest against the natural contour of the body
Request Customization: https://www.datamintelligence.com/enquiry/south-america-medical-oxygen-concentrators-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
An oxygen concentrator is a device that concentrates the oxygen from a gas supply by selectively removing nitrogen to supply an oxygen-enriched product gas stream. Medical oxygen concentrators are mainly in hospitals or at home to produce oxygen for patients.
Market Dynamics
The rising prevalence of asthma and COPD is one of the key factors driving the South America medical oxygen concentrators market, as these patients require purified oxygen. COPD is the most common disease in elderly population. It is a progressive illness that takes several years to develop. Most people are at least 40 years old when symptoms of COPD first appear. Its not impossible to develop COPD as a young adult, but it is rare. According to the Brazil Statistical Institute in 2017, in Brazil, people aged 65 and above are expected to reach 36% by 2050 and major percentage of asthma and COPD patients are of geriatric population. According to the National Health Survey in 2018, in Brazil, asthma affected more than 6 million adults.
In addition, increasing number of ICU cases is fueling the South America oxygen concentrators market. In critical care, the monitoring is essential to the daily care of ICU patients, the decisive endpoint is the supply of oxygen to tissues according to their metabolic needs in order to fuel mitochondrial respiration, therefore enhanced and purified oxygen supply is required in intensive care unit. According to Brazilian Critical Care Society in 2016, there were approximately 36,000 ICU beds in Brazil which is one of the largest number of ICU beds in the world per population. These ICU require oxygen concentrators to deliver purified oxygen. There were 25 ICU beds per 100,000 inhabitants 7.6 public ICU beds per 100,000 inhabitants.
However, the high cost of devices is hampering the growth of the South America medical oxygen concentrators market. The main cause of this extremely high cost is that current testing methods of evaluating medical oxygen concentrators are extremely time consuming and expensive as many patients must be tested over a long period of time. In case of bigger stationary oxygen concentrators, the initial set up of these concentrators is high which restrains the end-users from upgrading to the latest models. For instance, Oxygo portable ultra light medical oxygen cylinder is priced at $ 129 whereas the basic oxygen concentrator prices at $435. The maintenance and insurance of these devices are hampering the demand of oxygen concentrators market
Market Segmentation
By product type, the medical oxygen concentrators market is segmented into portable oxygen concentrators and stationary oxygen concentrators. Portable medical oxygen concentrators market holds 66% of market share in 2018, and is expected to increase by 67% by 2026, for South America medical oxygen concentrators market. A portable oxygen concentrator (POC) is a device used to provide oxygen therapy to people that requires greater oxygen concentrations than the levels of ambient air. Portable concentrators are made small enough to carry in one arm, in a backpack or attach to a cart or walker so the patient can move about freely at home or while traveling. Portable concentrators weighs between 5 and 20 pounds and many come with carrying cases or carts for additional convenience when compared to stationary oxygen concentrators. Portable oxygen concentrators provide greater flexibility for respiratory patients who do not require high doses of oxygen and they can run on a variety of power sources and can charge from a wall outlet, a car adapter, or a battery pack. Manufacturers are trying to enhance the portable concentrators to match the reliability and flow rates of stationary concentrators with the portability and convenience of a portable concentrator
By end-user, the hospital medical oxygen concentrators market holds largest market share of about 36% of market share in 2018, and is expected to increase by 37% by 2026, for South America medical oxygen concentrators market. Most of the oxygen concentrators are expensive, and hospitals can afford these devices as they have sufficient budget for all their medical equipment when compared to other medical facilities. The increasing number of hospitalizations for acute and chronic conditions such as respiratory disorders and cardiac diseases are boosting the requirement of oxygen concentrators in hospitals. According to International Journal Cardiovascular Science in 2017, coronary artery disease (CAD) accounted for approximately 250,000 hospitalizations. The high number of patients being admitted for respiratory conditions is compelling hospitals to spend more on these systems, leading to a rise in the revenue of oxygen concentrators
Download free sample: https://www.datamintelligence.com/download-sample/south-america-medical-oxygen-concentrators-market
Geographical Analysis
Brazil and Argentina are the two largest markets for Medical Oxygen Concentrators in the region, Rest of the countries in the regions cumulatively accounted for less than 40% of the South American market value for Medical Oxygen Concentrators in 2018. Relatively advanced healthcare infrastructure, healthcare spending and high population density in Brazil compared to other South American countries is the primary factor for the dominant share of the respiratory equipment market in the region. The market for respiratory equipment is untapped in many South American countries due to low healthcare access and low disease awareness. For instance, Argentina represents a potential market for respiratory equipment which more than 300,000 health professional and 5000+ hospitals in the country.
Competitive Landscape
The South America medical oxygen concentrators market is dominated by major players including Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Inogen Inc., Invacare Corporation, Dragerwerk AG & Co. KGaA, TEIJIN LIMITED, DeVilbiss Healthcare LLC, GCE Healthcare, O2 Concepts, LLC, among others.
he key players are focusing on broadening their product portfolio by partnering with or acquiring smaller companies or by launching new products. For instance,
In March 2019, Invacare launched the new BirdieEVO mobile hoist family.
In January 2019, ResMed, a leader in respiratory care medical devices and out-of-hospital care software launched premier portable oxygen concentrator, Mobi , which offers an optimal balance of oxygen delivery, weight and battery life so that millions of people with chronic obstructive pulmonary disease (COPD) or other chronic diseases can enjoy Res Med-quality oxygen therapy wherever they go.
In 2019, Inogen, leading medical device company recently launched Inogen One G5 portable oxygen concentrator. The Inogen One G5 is much superior to other portable oxygen concentrators because it has the highest oxygen production capacity per pound of weight, amounting to 1260 ml
In 2018, Caire Inc launched portable oxygen concentrator, the FreeStyle Comfort. The device weighs only 5 lbs and desigend with a comfort curve to rest against the natural contour of the body
Request Customization: https://www.datamintelligence.com/enquiry/south-america-medical-oxygen-concentrators-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results